Cargando…
Interleukin-6 upregulates SOX18 expression in osteosarcoma
AIM: SOX18 is a potential oncogene in osteosarcoma via controlling osteosarcoma cell proliferation and metastasis. Interleukin-6 (IL-6), a major activator of Janus kinase 2 (JAK2)/signal transducers and activators of transcription 3 (STAT3) signaling, plays an important role in the growth of carcino...
Autores principales: | Wu, Zhong, Yang, Weizhi, Liu, Junjian, Zhang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687486/ https://www.ncbi.nlm.nih.gov/pubmed/29184419 http://dx.doi.org/10.2147/OTT.S149905 |
Ejemplares similares
-
Upregulation of FTX Promotes Osteosarcoma Tumorigenesis by Increasing SOX4 Expression via miR-214-5p
por: Chen, Haicong, et al.
Publicado: (2020) -
Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients’ prognosis
por: Zhu, Haibo, et al.
Publicado: (2013) -
LncRNA WAC-AS1 promotes osteosarcoma Metastasis and stemness by sponging miR-5047 to upregulate SOX2
por: Yang, Zhining, et al.
Publicado: (2023) -
SOX12 Promotes Stem Cell-Like Phenotypes and Osteosarcoma Tumor Growth by Upregulating JAGGED1
por: Zhang, Weifei, et al.
Publicado: (2021) -
Upregulation of SOX18 in colorectal cancer cells promotes proliferation and correlates with colorectal cancer risk
por: Miao, Zuohua, et al.
Publicado: (2018)